Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 6,208 $ 21,418
Equity method investments 498,631 471,044
Real estate 362,265 365,370
Investments 74,530 169,793
Securitization assets 123,979 71,601
Other assets 162,054 111,027
Total Assets 2,387,274 2,154,913
Liabilities:    
Accounts payable, accrued expenses and other 53,538 36,509
Deferred funding obligations 813 72,100
Credit facilities 31,199 258,592
Non-recourse debt (secured by assets of $921 million and $1,105 million, respectively) 700,225 834,738
Senior unsecured notes 512,153 0
Convertible notes 149,434 148,451
Total Liabilities 1,447,362 1,350,390
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 66,338,120 and 60,510,086 shares issued and outstanding, respectively 663 605
Additional paid in capital 1,102,303 965,384
Accumulated deficit (169,786) (163,205)
Accumulated other comprehensive income (loss) 3,300 (1,684)
Non-controlling interest 3,432 3,423
Total Stockholders’ Equity 939,912 804,523
Total Liabilities and Stockholders’ Equity 2,387,274 2,154,913
Government receivables    
Assets    
Receivables, net of allowance 263,175 497,464
Commercial receivables    
Assets    
Receivables, net of allowance $ 896,432 $ 447,196